Jazz Pharmaceuticals plc — Director's Dealing 2025

Nov 24, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Jazz Pharmaceuticals plc (JAZZ)
CIK: 0001232524
Period of Report: 2025-11-20

Reporting Person: McSharry Heather Ann (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-11-20	Ordinary Shares	M	3415	$138.08	Acquired	23864	Direct
2025-11-20	Ordinary Shares	S	3415	$177.7823	Disposed	20449	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-11-20	Non-Qualified Stock Option (right to buy)	$138.08	M	3415	Disposed	2026-08-10	Ordinary Shares (3415)	Direct

Footnotes

F1: This non-qualified stock option was granted on August 11, 2016 and vested over a period of one year from September 1, 2016. The options were fully vested as of August 1, 2017.